Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SylvainL
    Senior Member
    • Feb 2012
    • 180

    #1

    Illumina sues Oxford Nanopore

    Hi all,

    Illumina sues Oxford Nanopore...

    http://www.genomeweb.com/sequencing-...t-infringement

    Curious to have your opinion about this....
  • NextGenSeq
    Senior Member
    • Apr 2009
    • 482

    #2
    Looks like ONT has become a threat.
    Illumina used to scoff at them.

    Competition is good for customers. Illumina is a one-trick pony and their technology is headed to the glue factory.

    Comment

    • narain
      Banned
      • Aug 2011
      • 73

      #3
      Patent fights converge to the more wealthy team as winner.

      Comment

      • Richard Finney
        Senior Member
        • Feb 2009
        • 701

        #4
        The patents in question as reported by BioIT World
        Discover the latest news in bioinformatics, biomedical research, and drug discovery. Bio-IT World provides topical news coverage and analysis of cutting-edge biotechnologies to deliver individualized medicine.


        Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.

        Mycobacterium smegmatis nanopores and related methods

        Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.

        MSP nanopores and related methods

        Comment

        • Brian Bushnell
          Super Moderator
          • Jan 2014
          • 2709

          #5
          Originally posted by SylvainL View Post
          Illumina sues Oxford Nanopore...
          Booo...

          Hopefully the fact that they are not a US company will shield them somewhat.

          Comment

          • dannyhi321
            Member
            • Jul 2014
            • 51

            #6
            Originally posted by narain View Post
            Patent fights converge to the more wealthy team as winner.
            That's blatantly not true, take the recent IBS V Illumina case as an example.

            Ever heard of David V Goliath?

            Comment

            • ymc
              Senior Member
              • Mar 2010
              • 496

              #7
              While it is likely that this is Illumina's tactic to stall or distract ONT, WashU being one of plaintiffs does give this claim a little bit of credibility.

              Comment

              • dannyhi321
                Member
                • Jul 2014
                • 51

                #8
                Originally posted by Brian Bushnell View Post
                Booo...

                Hopefully the fact that they are not a US company will shield them somewhat.
                I thought discrimination was not tolerated on this site!?

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
                  by SEQadmin2




                  NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
                  Yesterday, 06:46 AM
                • SEQadmin2
                  Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                  by SEQadmin2



                  Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                  Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                  ...
                  10-14-2026, 09:55 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 10-28-2026, 09:57 AM
                0 responses
                28 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-28-2026, 09:51 AM
                0 responses
                18 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-22-2026, 11:13 AM
                0 responses
                71 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 10-22-2026, 10:48 AM
                0 responses
                48 views
                0 reactions
                Last Post SEQadmin2  
                Working...